Structure |
Chemical Name |
CAS |
MF |
|
11-Prostaglandin F2a |
|
|
|
4-Formyl-2-isopropylthiazole |
133047-46-8 |
C7H9NOS |
|
Sodium 1-(2-hydroxyethyl)-1H-tetrazol-5-ylthiolate |
400827-72-7 |
C3H5N4NaOS |
|
(4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
C22H27N7O4S |
|
(6R,7S)-Cefuroxime |
|
C16H16N4O8S |
|
(6-methyl-2-p-tolyl-2,3-dihydro-imidazo[1,2-a]pyridin-3-yl)-oxoacetic acid |
927820-48-2 |
C17H14N2O3 |
|
Triphenylsulfonium chloride |
4270-70-6 |
C18H15ClS |
|
5-GERANOXY-7-METHOXYCOUMARIN |
7380-39-4 |
C20H24O4 |
|
ACETIC ACID 2-PHENOXYETHYL ESTER |
6192-44-5 |
C10H12O3 |
|
ETHYL 1-HYDROXYCYCLOPENTANE-CARBOXYLATE |
41248-23-1 |
C8H14O3 |
|
Danshen injection intermediate |
|
|
|
Azacitidine Isomer |
|
|
|
6-FLUORO-4-HYDROXYCOUMARIN |
1994-13-4 |
C9H5FO3 |
|
Cefazolin Related Compound D |
|
|
|
Sugammadex sodium hexabromide intermediate |
|
|
|
(3S,5R,2R,3S)-posaconazole |
|
|
|
2',3',5'-TRI-O-BENZOYLINOSINE |
6741-88-4 |
C31H24N4O8 |
|
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
641569-94-0 |
C17H14N4O2 |
|
4-Bromopyrazole |
2075-45-8 |
C3H3BrN2 |
|
Fendizoic acid |
84627-04-3 |
C20H14O4 |
|
Lysergamide, 1-acetyl-N,N-diethyl- (6CI,7CI) |
3270-02-8 |
C22H27N3O2 |
|
4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester |
5948-71-0 |
C14H15ClN2O3 |
|
2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile |
1187595-85-2 |
C7H10N2O2S |
|
4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
170985-61-2 |
C37H42F2N8O4 |
|
Velpatasvir intermediate |
1378391-45-7 |
C44H53N7O7 |
|
Br-PEG1-NHBoc |
164332-88-1 |
C9H18BrNO3 |
|
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride |
1701403-10-2 |
C22H23ClN6O |
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid |
1616342-45-0 |
C15H16N2O6 |
|
Coumarin 102 |
41267-76-9 |
C16H17NO2 |
|
L-Cephalexin |
34632-04-7 |
C16H17N3O4S |
|
Rimonabant hydrochloride |
158681-13-1 |
C22H21Cl3N4O.ClH |
|
5-bromo-2-chloro-4’-ethoxydiphenylmethane |
461432-23-5 |
C15H14BrClO |
|
3-isobutylglutaric anhydride |
185815-59-2 |
C9H14O3 |
|
7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID |
80370-59-8 |
C13H12N2O5S2 |
|
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
|
8-bromo-1,4-dioxaspiro[4.5]decane |
68278-51-3 |
C8H13BrO2 |
|
Retigabine Dihydrochloride |
150812-13-8 |
C16H20Cl2FN3O2 |
|
QUINUCLIDINE |
100-76-5 |
C7H13N |
|
6-nitrocoumarin |
2725-81-7 |
C9H5NO4 |
|
(S)-1-Amino-3-chloro-2-propanol hydrochloride |
34839-13-9 |
C3H9Cl2NO |
|
9β,11β-Epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione |
981-34-0 |
C22H28O5 |
|
3,4-Dichloro-6-(trifluoromethyl)toluene |
74483-51-5 |
C8H5Cl2F3 |
|
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
|
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine |
941685-27-4 |
C15H21N5OSi |
|
4,7-Bis(2-bromo-5-thienyl)-2,1,3-benzothiadiazole |
288071-87-4 |
C14H6Br2N2S3 |
|
(1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
895152-66-6 |
C16H19NO |
|
Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- |
61848-66-6 |
C6H12Cl2N2Pt |
|
20-HYDROXY PROSTAGLANDIN E2 |
57930-95-7 |
C20H32O6 |
|
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
|
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
|
(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate |
186488-43-7 |
C8H12O4 |
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
C20H17BrN6O2 |
|
DMT-2′O-MOE-rMeC(bz) Phosphoramidite |
163759-94-2 |
C50H60N5O10P |
|
Methyl (R)-4,4-difluoropyrrolidine-2-carboxylate hydrochloride |
1408057-39-5 |
C6H10ClF2NO2 |
|
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
|
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
|
McMMAE |
863971-24-8 |
C49H78N6O10 |
|
2-Amino-4-bromo-3-fluorobenzoic acid |
1416013-62-1 |
C7H5BrFNO2 |
|
4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)Methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)Methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
1246391-73-0 |
C37H42F2N8O4 |
|
Neratinib Maleate |
915942-22-2 |
C34H33ClN6O7 |
|
Oclacitinib Maleate(PF-03394197) |
1208319-27-0 |
C19H27N5O6S |
|
4,6,7-trihydroxycoumarin |
22649-24-7 |
C9H6O5 |
|
Velpatasvir intermediate |
1378391-42-4 |
C31H34BrNO8 |
|
Methyl 4-isopropyl-3,5-dimethoxybenzoate |
344396-17-4 |
C13H18O4 |
|
ETHYL 3-BUTENOATE |
1617-18-1 |
C6H10O2 |
|
Secondary Prostaglandin Metabolite LC-MS Mixture |
|
|
|
Indoline |
496-15-1 |
C8H9N |
|
3-CYANOCOUMARIN |
15119-34-3 |
C10H5NO2 |
|
((1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5,6-dimethyl-6-(trimethylsilyloxy)hept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)cyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldimethylsilane) |
2186604-89-5 |
C42H80O3Si3 |
|
Anti-Cyclooxygenase 3/Cox3 |
|
|
|
Ceftazidime and Avibactam Sodium for Injection |
|
|
|
13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 |
59894-07-4 |
C20H32O5 |
|
9ALPHA,15S-DIHYDROXY-11-OXO-PROST-13E-EN-1-OIC ACID |
17968-82-0 |
C20H34O5 |
|
9-OXO-11ALPHA-15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC-3,3,4,4-D4 ACID |
34210-10-1 |
C20H28D4O5 |
|
5-(4-Hydroxyphenyl)-2,4-imidazolidinedione |
2420-17-9 |
C9H8N2O3 |
|
2-Azepan-1-yl-ethylamine |
51388-00-2 |
C8H18N2 |
|
4,7-DIHYDROXYCOUMARIN |
1983-81-9 |
C9H6O4 |
|
(9H-fluoren-9-yl)methyl (S)-(1-(methylamino)-1-oxo-5-ureidopentan-2-yl)carbamate |
|
|
|
(9H-fluoren-9-yl)methyl (S)-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)carbamate |
|
|
|
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
118864-75-8 |
C15H15N |
|
(2S,3R)-2-amino-3-methylpent-4-enamide |
2209873-96-9 |
C6H12N2O |
|
4alpha,5-epoxy-5alpha-androst-2-eno[2,3-d]isoxazol-17beta-ol |
20051-76-7 |
C20H27NO3 |
|
Carbamazepine intermediate |
|
|
|
(6R,7S)-Ceftriaxone Epimer |
|
|
|
2-Cyanoethyl 3-oxobutanoate |
65193-87-5 |
C7H9NO3 |
|
Cefcanel |
41952-52-7 |
C19H18N4O5S3 |
|
Eseroline |
469-22-7 |
C13H18N2O |
|
(1S,2R,3S,5R)-2-(Benzyloxymethyl)-6-oxabicyclo[3.1.0]hexan-3-ol |
117641-39-1 |
C13H16O3 |
|
3,4-Diiodopyrazole |
6645-70-1 |
C3H2I2N2 |
|
(6β)-3-(1-Methyl-1H-tetrazole-5-ylthiomethyl)-7α-amino-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid benzhydryl ester |
66510-99-4 |
C24H24N6O5S |
|
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate |
571188-59-5 |
C14H22N4O2 |
|
N2-Isobutyryl-2'-Fluoro-2'-deoxyguanosine |
80681-25-0 |
C14H18FN5O5 |
|
BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl- |
885126-34-1 |
C15H12IN3OS |
|
ForMoterol-IMpurity-B |
1224588-66-2 |
C18H22N2O4 |
|
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
477600-73-0 |
C20H25N5 |
|
3-(1,1-diMethylethyl)-7a-ethenyltetrahydro-1-hydroxy-(3R,7aR)-3H,5H-Pyrrolo[1,2-c]oxazol-5-one |
1214741-21-5 |
C12H19NO3 |
|
(S)-1-(2-(1-aMino-2-Methylpropan-2-ylaMino)acetyl)pyrrolidine-2-carbonitrile dihydrochloride (AMino pyrrolidine) |
739364-93-3 |
C11H22Cl2N4O |
|
AMinopentaMide Sulfate |
20701-77-3 |
C19H26N2O5S |
|
(Ac)Phe-Lys(Alloc)-PABC-PNP |
|
C??H??N?O?? |